The United States Food and Drug Administration Commissioner suggests using blockchain as a pilot for the pharma industry mostly focused on improving the supply chains and was first announced in a published notice two days ago and we are about to find out more in today’s blockchain news.
The pilot program or Under The Drug Supply Chain Security Act (DSCSA Pilot Project Program), that has a goal to integrate all the major industry players that have some of the most innovative technologies, will accept applications until March 11.
This is a huge step forward in the development of the supply chain platform that is created especially to track drugs and prevent counterfeiting and the project is due 2023. The FDA Commissioner Scott Gottlieb noted in a press release:
“We’re invested in exploring new ways to improve traceability, in some cases using the same technologies that can enhance drug supply chain security, like the use of blockchain.”
The DSCSA has its starting point back in 2013 when it was hoping to build an interoperable and electronic system that will help trace and identify certain drugs prescription. The press release states:
“Enhanced verification and tracing in the supply chain can translate to a more rapid response by industry and the FDA when an illegitimate product is found.’’
The FDA didn’t hint at which exact participants the pilot is meant for or the ones who already expressed interest. The pharma industry is one of the industries where blockchain can provide solutions. The supply chains around the world are seeing similar treatment and there are plenty who are already using the blockchain technology.
DC Forecasts is a leader in many crypto news categories, striving for the highest journalistic standards and abiding by a strict set of editorial policies. If you are interested to offer your expertise or contribute to our news website, feel free to contact us at [email protected]
Discussion about this post